Funding for this research was provided by:
The Research Council of Norway (234457)
Received: 5 October 2019
Accepted: 6 February 2020
First Online: 12 February 2020
Ethics approval and consent to participate
: The study was approved by the Regional Committee for Medical and Health Research Ethics of Western Norway (REK Vest) (2014/46/REK vest). An exemption from informed consent from the patients was granted as the study only included residual material from samples sent for TB diagnostics in the clinical setting.
: Not applicable
: The authors declare that they have no competing interests.